Connect your AI

TransMedics Group, Inc. TMDX Inventories

Inventories at other companies

LivaNovaLIVN

$165.5M+7.5%

ICU MedicalICUI

$605.59M+2.6%

Edwards LifesciencesEW

$1.12B+0.5%

United TherapeuticsUTHR

$178.3M+7.8%

OSI SystemsOSIS

$435.29M-0.8%

Other financials

Income statement

Revenue$173.9M+21.2%

Gross profit$101.2M+14.7%

Operating income$13.3M-51.5%

Net income$7.3M-71.5%

EPS (diluted)$0.20-71.4%

Balance sheet

Cash & equivalents$461.7M+48.9%

Total debt$409.9M+505%

Total equity$494.0M+85.5%

Total assets$1.4B+71.3%

Cash flow

Operating cash flow$24.5M+959%

CapEx$36.7M+35.6%

Free cash flow-$12.1M+59.4%

Valuation

Market cap$2.55B+50.6%

Enterprise value$2.5B+66.0%

P/E14.8×-19.8×

P/S4×+0.5×

Profitability

Gross margin59.1%-0.4pp

Operating margin14.9%+4.1pp

Net margin27%+17.0pp

FCF margin23.8%—

Returns & leverage

Return on equity45.2%+22.2pp

Debt / equity0.8×+0.6×

Current ratio6.7×-2.4×

Where this comes from

Reported directly by TransMedics Group, Inc. in its filing.

Tagged under the XBRL concept us-gaap:InventoryNet.

The official record: TransMedics Group, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about TransMedics Group, Inc.'s inventories.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is TransMedics Group, Inc.'s inventories?: TransMedics Group, Inc. (TMDX) reported inventories of $49.89M in Q1 2026.
How has TransMedics Group, Inc.'s inventories changed year-over-year?: TransMedics Group, Inc.'s inventories increased by 15.0% year-over-year, from $43.38M to $49.89M.
What is the long-term trend for TransMedics Group, Inc.'s inventories?: Over 5 years (2020 to 2025), TransMedics Group, Inc.'s inventories has grown at a 32.6% compound annual growth rate (CAGR), from $11.93M to $48.88M.
What does inventories mean?: Total inventory including raw materials, work-in-progress, and finished goods, valued at the lower of cost or net realizable value.